We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+11.59%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$72.4B
AUM Growth
+$15.6B
(+27%)
Cap. Flow
+$9.22B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
28.56%
Holding
1,592
New
27
Increased
724
Reduced
266
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$653M |
| 2 |
UnitedHealth
UNH
|
+$608M |
| 3 |
Apple
AAPL
|
+$472M |
| 4 |
NVIDIA
NVDA
|
+$378M |
| 5 |
Amazon
AMZN
|
+$376M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$164M |
| 2 |
Danaher
DHR
|
+$126M |
| 3 |
Philip Morris
PM
|
+$118M |
| 4 |
Nike
NKE
|
+$40.8M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$12.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.24% |
| 2 | Healthcare | 14.81% |
| 3 | Financials | 13.58% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Communication Services | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Xencor
XNCR
$1.71B
| $270K | ﹤0.01% |
12,184
-541
| -4% | -$11.7K |
|
|
ALX
927
Alexander's
ALX
$1.4B
| $262K | ﹤0.01% |
1,205
| – | – |
|
928
ICICI Bank
IBN
$106B
| $259K | ﹤0.01% |
9,800
| – | – |
|
|
LAND
929
Gladstone Land Corp
LAND
$358M
| $259K | ﹤0.01% |
19,400
| – | – |
|
930
Q2 Holdings
QTWO
$4.13B
| $256K | ﹤0.01% |
4,878
-136
| -3% | -$6.15K |
|
931
HDFC Bank
HDB
$119B
| $256K | ﹤0.01% |
9,142
| – | – |
|
|
FOLD
932
DELISTED
Amicus Therapeutics
FOLD
| $255K | ﹤0.01% |
21,688
-975
| -4% | -$12.5K |
|
|
LEV
933
DELISTED
The Lion Electric Company
LEV
| $255K | ﹤0.01% |
179,865
-14,037
| -7% | -$22.7K |
|
|
VERV
934
DELISTED
Verve Therapeutics
VERV
| $252K | ﹤0.01% |
19,013
-871
| -4% | -$11.6K |
|
935
Beam Therapeutics
BEAM
$2.74B
| $252K | ﹤0.01% |
7,640
-350
| -4% | -$10.9K |
|
936
Nu Holdings
NU
$67.3B
| $250K | ﹤0.01% |
20,951
-1,826
| -8% | -$18.6K |
|
937
Recursion Pharmaceuticals
RXRX
$1.78B
| $248K | ﹤0.01% |
24,914
-1,141
| -4% | -$12.7K |
|
938
Marathon Digital Holdings
MARA
$3.56B
| $248K | ﹤0.01% |
10,987
-1,051
| -9% | -$23K |
|
939
Regenxbio
RGNX
$704M
| $247K | ﹤0.01% |
11,732
-538
| -4% | -$9.57K |
|
940
IDEAYA Biosciences
IDYA
$3.53B
| $243K | ﹤0.01% |
5,545
-254
| -4% | -$10.9K |
|
941
Vir Biotechnology
VIR
$1.52B
| $243K | ﹤0.01% |
23,979
-1,099
| -4% | -$11.2K |
|
942
Rocket Companies
RKT
$42.6B
| $242K | ﹤0.01% |
16,625
-1,588
| -9% | -$19.7K |
|
943
Novartis
NVS
$288B
| $239K | ﹤0.01% |
2,467
-113
| -4% | -$11.6K |
|
944
Arrowhead Research
ARWR
$12.1B
| $239K | ﹤0.01% |
8,341
-373
| -4% | -$11.9K |
|
945
CONMED
CNMD
$1.49B
| $236K | ﹤0.01% |
2,953
-137
| -4% | -$12.2K |
|
|
NVEI
946
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $231K | ﹤0.01% |
7,296
-648
| -8% | -$16.4K |
|
947
PagSeguro Digital
PAGS
$2.43B
| $230K | ﹤0.01% |
16,122
-1,447
| -8% | -$19.1K |
|
948
CRISPR Therapeutics
CRSP
$5.22B
| $227K | ﹤0.01% |
3,332
-149
| -4% | -$10.7K |
|
949
Cipher Digital
CIFR
$6.9B
| $224K | ﹤0.01% |
43,527
-3,621
| -8% | -$12.5K |
|
|
HAPN
950
Happen Inc
HAPN
$2.27B
| $223K | ﹤0.01% |
25,388
-2,373
| -9% | -$19.9K |
|
Similar funds
Mitsubishi UFJ Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Mitsubishi UFJ Asset Management held 1,592 positions worth $72.4B, up 27% from $56.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Mitsubishi UFJ Asset Management deployed $9.22B of net new capital in Q1 2024, opening 27 new positions and adding to 724 existing holdings. Its largest new stake was Maplebear: 173,300 shares worth $6.46M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $164M trimmed.
- Mitsubishi UFJ Asset Management's largest Q1 2024 buy was Maplebear: 173,300 shares worth $6.46M.
- Mitsubishi UFJ Asset Management added most to Microsoft in Q1 2024, an estimated $653M increase.
- Mitsubishi UFJ Asset Management's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $164M.
- Mitsubishi UFJ Asset Management fully exited Splunk Inc in Q1 2024, selling an estimated $12.6M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 29% of its $72.4B portfolio in Q1 2024.
- Mitsubishi UFJ Asset Management opened 27 new positions and closed 28 in Q1 2024.
- Mitsubishi UFJ Asset Management's portfolio value rose 27% quarter-over-quarter to $72.4B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2024, filed 9 May 2024.